What do systematic reviews say?

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs placebo

• Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 163 participants
  GRADE not reported

PUL vs TURP

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 72 participants
  Low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Low

PUL vs TURP

It is very uncertain whether PUL changes retreatment compared with TURP (very low certainty).

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 2.39 [0.51, 11.1]
  1 study · 79 participants
  Very low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 1.19 [0.21, 6.75]
  1 study · 79 participants
  Very low

PUL vs TURP

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 57 participants
  Moderate
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 59 participants
  Moderate

PUL vs TURP

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 56 participants
  Low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 59 participants
  Moderate

PUL vs sham

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 206 participants
  Low

PUL vs sham

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 206 participants
  Moderate

PUL vs sham

It is very uncertain whether PUL changes major adverse events compared with sham (very low certainty).

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 3.3 [0.41, 26.28]
  1 study · 206 participants
  Very low

PUL vs sham

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 206 participants
  Low

PUL vs sham

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 197 participants
  Moderate

PUL vs sham

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 144 participants
  Moderate

PUL vs TURP

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 72 participants
  Low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Low

PUL vs TURP

It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 0.64 [0.18, 2.19]
  1 study · 79 participants
  Very low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)

Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in limb salvage rate compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  RR 0.84 [0.49, 1.45]
  2 studies · 936 participants
  Low

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

The review found no eligible studies for this question.

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

The review found no eligible studies for this question.

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

The review found no eligible studies for this question.

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

The review found no eligible studies for this question.

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term)

The review found no eligible studies for this question.

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term)

Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in vessel or graft secondary patency compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).

• Duplex ultrasound for surveillance of lower limb revascularisation 2023 · Cochrane Headline outcomes only
  RR 0.92 [0.67, 1.26]
  3 studies · 1092 participants
  Low